We are live on
!
Find out more
R.M. Davis Inc Portfolio holdings
AUM
$6.34B
Turnover
7.99%
1-Year Est. Return
29%
This Fund
S&P 500
This Quarter
Est. Return
+5.4%
1 Year Est. Return
+29%
3 Year Est. Return
+85.15%
5 Year Est. Return
+109.05%
10 Year Est. Return
+412.04%
AUM
$2.37B
AUM Growth
+$154M
(+6.9%)
Cap. Flow
+$41.7M
Cap. Flow
% of AUM
1.76%
Top 10 Holdings %
Top 10 Hldgs %
22.15%
Holding
229
New
10
Increased
75
Reduced
114
Closed
9
Avg Time Held
2.9
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 3000 ETF
IWV
|
+$22.3M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$19.5M |
| 3 |
Cullen/Frost Bankers
CFR
|
+$13.2M |
| 4 |
Constellation Brands
STZ
|
+$5.11M |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$21.3M |
| 2 |
Accenture
ACN
|
+$4.71M |
| 3 |
Dick's Sporting Goods
DKS
|
+$3.7M |
| 4 |
Hain Celestial
HAIN
|
+$3.33M |
| 5 |
Idexx Laboratories
IDXX
|
+$2.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.49% |
| 2 | Technology | 14% |
| 3 | Financials | 11.12% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.3B
| $2.08M | 0.09% |
6,561
+135
| +2% | +$42.5K |
2013 Q2
16 quarters
|
|
102
TechnipFMC
FTI
$27.3B
| $2.04M | 0.09% |
100,984
+15,254
| +18% | +$344K |
2013 Q2
16 quarters
|
|
103
Amazon
AMZN
$2.74T
| $2.03M | 0.09% |
41,900
+2,800
| +7% | +$134K |
2013 Q3
15 quarters
|
|
104
Home Depot
HD
$295B
| $1.96M | 0.08% |
12,750
-455
| -3% | -$69.8K |
2013 Q2
16 quarters
|
|
105
Vulcan Materials
VMC
$31.3B
| $1.73M | 0.07% |
13,660
+1,000
| +8% | +$126K |
2013 Q2
16 quarters
|
|
106
Abbott
ABT
$178B
| $1.7M | 0.07% |
34,960
-5,866
| -14% | -$266K |
2013 Q2
16 quarters
|
|
107
Pfizer
PFE
$166B
| $1.67M | 0.07% |
52,389
-12,443
| -19% | -$392K |
2013 Q2
16 quarters
|
|
108
AT&T
T
$158B
| $1.65M | 0.07% |
57,783
-6,763
| -10% | -$199K |
2013 Q2
16 quarters
|
|
109
Verizon
VZ
$185B
| $1.59M | 0.07% |
35,709
-4,381
| -11% | -$204K |
2013 Q2
16 quarters
|
|
110
Coca-Cola
KO
$395B
| $1.46M | 0.06% |
32,507
-2,564
| -7% | -$113K |
2013 Q2
16 quarters
|
|
111
Vanguard Morningstar Small-Cap ETF
VB
$76.8B
| $1.43M | 0.06% |
10,546
+82
| +0.8% | +$11K |
2013 Q2
16 quarters
|
|
112
Lowe's Companies
LOW
$106B
| $1.39M | 0.06% |
17,916
+200
| +1% | +$16.3K |
2013 Q2
16 quarters
|
|
113
DELISTED
Du Pont De Nemours E I
DD
| $1.31M | 0.06% |
16,253
+44
| +0.3% | +$3.52K |
2013 Q2
16 quarters
|
|
114
iShares Russell 2000 ETF
IWM
$76.4B
| $1.3M | 0.06% |
9,250
+138
| +2% | +$19.1K |
2013 Q2
16 quarters
|
|
115
Gilead Sciences
GILD
$190B
| $1.27M | 0.05% |
17,936
-26,013
| -59% | -$1.73M |
2014 Q3
11 quarters
|
|
116
Philip Morris
PM
$320B
| $1.21M | 0.05% |
10,340
-3,179
| -24% | -$368K |
2013 Q2
16 quarters
|
|
117
Bristol-Myers Squibb
BMY
$121B
| $1.14M | 0.05% |
20,428
-7,250
| -26% | -$395K |
2013 Q2
16 quarters
|
|
118
Boeing
BA
$146B
| $1.09M | 0.05% |
5,500
-144
| -3% | -$26.8K |
2013 Q2
16 quarters
|
|
119
Clorox
CLX
$10.3B
| $1.07M | 0.05% |
8,050
| – | – |
2013 Q2
16 quarters
|
|
120
Invesco S&P 500 Equal Weight ETF
RSP
$96.9B
| $1.06M | 0.04% |
11,467
+205
| +2% | +$18.8K |
2013 Q2
16 quarters
|
|
121
Illinois Tool Works
ITW
$76.7B
| $1.04M | 0.04% |
7,288
-157
| -2% | -$21.9K |
2013 Q2
16 quarters
|
|
122
Enterprise Products Partners
EPD
$77.3B
| $1.03M | 0.04% |
38,112
+80
| +0.2% | +$2.17K |
2013 Q2
16 quarters
|
|
123
iShares Russell Mid-Cap ETF
IWR
$55.9B
| $1.03M | 0.04% |
21,488
-2,424
| -10% | -$115K |
2013 Q2
16 quarters
|
|
124
Eli Lilly
LLY
$1.08T
| $1.03M | 0.04% |
12,511
-1,316
| -10% | -$107K |
2013 Q2
16 quarters
|
|
125
Deere & Co
DE
$175B
| $1.01M | 0.04% |
8,214
-840
| -9% | -$98.6K |
2013 Q2
16 quarters
|
|
Similar funds
R.M. Davis Inc's Q2 2017 Portfolio in Review
As of Q2 2017, R.M. Davis Inc held 229 positions worth $2.37B, up 6.9% from $2.21B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
R.M. Davis Inc's Q2 2017 filing shows 10 new, 75 increased, 114 reduced and 9 closed positions. Its largest new stake was Cullen/Frost Bankers: 142,760 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $21.3M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Financials.
- R.M. Davis Inc's largest Q2 2017 buy was Cullen/Frost Bankers: 142,760 shares worth $13.4M.
- R.M. Davis Inc added most to iShares Russell 3000 ETF in Q2 2017, an estimated $22.3M increase.
- R.M. Davis Inc's biggest Q2 2017 reduction was CR Bard Inc., cutting an estimated $21.3M.
- R.M. Davis Inc fully exited Hain Celestial in Q2 2017, selling an estimated $3.33M.
- R.M. Davis Inc's ten largest holdings make up 22% of its $2.37B portfolio in Q2 2017.
- R.M. Davis Inc opened 10 new positions and closed 9 in Q2 2017.
- R.M. Davis Inc's portfolio value rose 6.9% quarter-over-quarter to $2.37B.
Based on R.M. Davis Inc's 13F filing for Q2 2017, filed 31 Jul 2017.